← All trials
NCT05908643
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2023
- Primary completion
- Feb 28, 2025
- Completion date
- Dec 31, 2029
- First posted
- Jun 18, 2023
- Last posted
- Jun 18, 2023
- Enrollment
- 16
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Neogap TherapeuticsLead sponsor
- Clinical Trial Consultants ABCollaborator
- Karolinska InstituteCollaborator
- Region VästmanlandCollaborator
- Karolinska InstituteOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.